![tribune tribune](https://i.tribune.com.pk/media/images/ipiccy_image-(2)1699650956-0/ipiccy_image-(2)1699650956-0.jpg)
In an unexpected twist that has left fans buzzing with excitement, Aamir Khan has reportedly secured the life rights of former Indian cricketer Yuvraj Singh, as revealed in an exclusive article by Filmfare. This acquisition sets the stage for a compelling cinematic journey that will delve into the highs and lows of one of India's cricketing legends.
Singh's life has been nothing short of a rollercoaster, marked by his stellar cricketing achievements and a brave battle against cancer. Khan, renowned for his methodical approach to filmmaking and his knack for bringing riveting stories to life on the big screen, is all set to direct this project.
The news has sent ripples of excitement through the industry, and fans can't wait to witness Khan's interpretation of the various dimensions of Singh's remarkable journey.
It was also announced in July this year that Khan and Rajkumar Hirani, who last worked together in the 2014 film PK, and prior to that, in 3 Idiots (2009), are set to reunite for a biopic. "It's a known fact that Aamir Khan and Rajkumar Hirani are extremely fond of each other, and have been wanting to collaborate again for a while. They have even discussed many concepts in the past, and it seems they have finally found a subject that both of them like. It's a biopic, and when Aamir heard the idea, he instantly got excited," a source close to the development was quoted as saying by Pinkvilla.
Nevertheless, it remains to be confirmed whether the actor-director duo was contemplating a Yuvraj Singh biopic, or whether this is something Khan aims to do entirely on his own. As we anticipate more details, there’s no denying a blend of Singh’s journey and Khan’s cinematic prowess promises a film worth waiting for.
Have something to add to the story? Share it in the comments below.
COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ